Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-12

Clinical Trial Update: Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the use of epoetin beta in patients with chronic hepatitis C. The study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NeoRecormon (epoetin beta) (epoetin beta)

Snippet

Sponsor: University Hospital, Angers | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED